Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia

被引:0
|
作者
Ramezanali, Fariba [1 ]
Khalili, Gholamreza [2 ]
Arabipoor, Arezoo [1 ]
Lankarani, Narges Bagheri [2 ]
Moini, Ashraf [1 ]
机构
[1] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Endocrinol & Female Infertil, POB 16635-148, Tehran, Iran
[2] ACECR, Royan Inst Reprod Biomed, Reprod Epidemiol Res Ctr, Dept Epidemiol & Reprod Hlth, Tehran, Iran
关键词
Polycystic Ovary Syndrome; Endometrial Hyperplasia; Luteinizing Hormone; Body Mass Index;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The endometrial hyperplasia measured by ultrasound in polycystic ovary syndrome (PCOS) women is strongly related to pathologic endometrial thickness, but there is no consensus on the relation between serum luteinizing hormone (LH) and either of these factors: pathologic endometrial hyperplasia and body mass index (BMI). Materials and Methods: In this observational cross-sectional study, three hundred fifty infertile PCOS women were involved in this research. An endometrial biopsy was taken by using a pipelle instrument, regardless of menstrual cycle's day and all samples were reported by the same pathologist. Basal serum LH level was compared between two subgroups (hyperplasia and non-hyperplasia). The intended population was divided into three groups according to BMI and basal serum LH, later on the comparison was made in three groups. Chi-square test was applied to compare nominal variables between groups. Mann-Whitney U, and one way ANOVA tests were used to compare means on the basis of the result of normality test. Results: The frequency of endometrial hyperplasia was 2.6%. Endometrial thickness in the patients with endometrial hyperplasia was significantly higher than that of a normal endometrium (10.78 +/- 3.70 vs. 7.90 +/- 2.86 respectively, P=0.020). There was no relation between endometrial hyperplasia and serum LH (P=0.600). The ANOVA test showed serum LH levels were not the same among three BMI groups (P=0.007). Post hoc test was also performed. It showed that the LH level in normal BMI group was significantly higher than those of other groups (P=0.005 and P=0.004), but there was no statistical difference between overweight and obese groups (P=0.8). We found no relationship between BMI and endometrial thickness in PCOS patients (P=0.6). Conclusion: Sonographic endometrial stripe thickness is predictive for endometrial hyperplasia in PCOS women. We could not find out any relationship between serum LH level and BMI with endometrial thickness in PCOS patients. However, our study confirmed a diverse relationship between serum LH level and BMI in PCOS patients.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [31] Body Mass Index of Patients with Endometrial Hyperplasia Comparison to Patients with Proliferative Endometrium and Abnormal Bleeding
    Heller, Debra S.
    Mosquera, Claudia
    Goldsmith, Laura T.
    Cracchiolo, Bernadette
    JOURNAL OF REPRODUCTIVE MEDICINE, 2011, 56 (3-4) : 110 - 112
  • [32] Comment on the grouping of patients with polycystic ovary syndrome based on body mass index
    Wei, Jie
    HUMAN REPRODUCTION, 2022, 37 (01) : 193 - 193
  • [33] Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome
    Tamimi, Waleed
    Siddiqui, Imran A.
    Tamim, Hani
    AlEisa, Nada
    Adham, Maysoon
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 107 (01) : 54 - 57
  • [34] Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index
    Orvieto, Raoul
    Nahum, Ravit
    Meltcer, Simion
    Homburg, Roy
    Rabinson, Jacob
    Anteby, Eyal Y.
    Ashkenazi, Jacob
    REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 18 (03) : 333 - 336
  • [35] Correlation between serum thyroid stimulating hormone level and glycolipid metabolism in patients with polycystic ovary syndrome
    Chen, Zhongyu
    Jing, Shui
    Sun, Yanyan
    MEDICINE, 2023, 102 (52) : E36791
  • [36] Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome:: Investigation of hypothalamic and pituitary contributions
    Pagán, YL
    Srouji, SS
    Jimenez, Y
    Emerson, A
    Gill, S
    Hall, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04): : 1309 - 1316
  • [37] Relationship between body mass index and transvaginal ultrasonographic endometrial thickness in postmenopausal women
    Douchi, T
    Yoshinaga, M
    Katanozaka, M
    Mitani, M
    Nagata, Y
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1998, 77 (09) : 905 - 908
  • [38] Increased epicardial fat thickness is related with body mass index in women with polycystic ovary syndrome
    Soydinc, E.
    Soydinc, S.
    Ariturk, Z.
    Tekbas, E.
    Cakici, M.
    Islamoglu, Y.
    Ercan, S.
    Sari, I.
    Davutoglu, V.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (15) : 2111 - 2113
  • [39] Correlation between abdominal visceral fat and the risk of endometrial cancer in patients with polycystic ovary syndrome
    Zhang, Jiyan
    AFRICAN HEALTH SCIENCES, 2024, 24 (03) : 180 - 187
  • [40] Endometrial thickness measurement throughout a menstrual cycle in non-obese infertile patients with polycystic ovary syndrome
    Eryilmaz, Ozlem Gun
    Sarikaya, Esma
    Gulerman, Cavidan
    Akar, Serra
    Cicek, Nedim
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (06) : 1597 - 1600